carvedilol has been researched along with carbon tetrachloride in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Campos-Esparza, Mdel R; Cervantes-García, D; Elías-Flores, TG; Gerardo-Rodríguez, M; Llamas-Ramírez, RW; Muñoz-Fernández, L; Muñoz-Ortega, MH; Romero-Delgadillo, NI; Tavares-Rodríguez, Ede J; Ventura-Juárez, J | 1 |
| Abdel-Kawy, HS | 1 |
| Li, G; Li, Z; Ling, L; Meng, D; Wang, G; Zhang, C | 1 |
4 other study(ies) available for carvedilol and carbon tetrachloride
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Doxazosin Treatment Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Hamsters through a Decrease in Transforming Growth Factor β Secretion.
Topics: Adrenergic alpha-1 Receptor Antagonists; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Carbazoles; Carbon Tetrachloride; Carvedilol; Collagen Type I; Cricetinae; Doxazosin; Liver; Liver Cirrhosis; Liver Function Tests; Propanolamines; Serum Albumin; Transforming Growth Factor beta | 2016 |
Effect of carvedilol versus propranolol on acute and chronic liver toxicity in rats.
Topics: Acetaminophen; Adrenergic beta-Antagonists; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Carbon Tetrachloride; Carvedilol; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Glutathione; Hepatic Stellate Cells; Liver; Liver Cirrhosis, Experimental; Male; Malondialdehyde; Oxidative Stress; Propranolol; Rats, Wistar; Tumor Necrosis Factor-alpha | 2021 |
Carvedilol improves liver cirrhosis in rats by inhibiting hepatic stellate cell activation, proliferation, invasion and collagen synthesis.
Topics: Administration, Oral; Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Carbon Tetrachloride; Carvedilol; Cell Line; Cell Movement; Cell Proliferation; Collagen Type I; Fibronectins; Gene Expression Regulation; Hepatic Stellate Cells; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Male; Rats; Rats, Wistar; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1 | 2019 |